New regional identity unites a more than $100 billion bioscience ecosystem and positions Indiana among the world's leading innovation hubs.

BIO International Convention in San Diego, the CEOs of Indiana Corporate Partnership announced the bioscience sector across Indiana will now be known as "BioHeartland Indiana."

For more than a century, Indiana's life sciences ecosystem has been inventing, making and moving bioscience solutions at global scale across human health, animal health and plant science. The state's leading role in the GLP-1 revolution is a tangible example of what's possible when discovery, research, development, manufacturing and distribution exist within a single connected ecosystem.

With Eli Lilly, Elanco Animal Health, and Corteva, the region is home to global leaders in human health, animal health, and plant science. The state's four R1 universities, the nation's largest medical school, and the Indiana Bioscience Research Institute, combined with the industry researchers, serve to generate 3x the national average for issued patents. The biosciences sector contributes over $100B of economic activity to the state.

"Indiana is a powerhouse in human, animal and plant biosciences, but our story has not been told with the clarity, consistency or urgency it deserves," said Melina Kennedy, CEO of the CEOs of Indiana Corporate Partnership. "What makes this region different is not just that we make bioscience solutions, we are also a hotbed of invention and discovery, with the manufacturing strength, logistics infrastructure and collaborative spirit to move innovations into the world. BioHeartland gives us a shared identity to help investors, companies and talent understand the full value of what Indiana offers."

The announcement follows Governor Mike Braun's $1 billion commitment to help Indiana's life sciences companies accelerate growth over the next ten years.

"People will hear the words 'BioHeartland Indiana' and automatically think, "that's a place open for science and innovation where industry professionals across the entire value chain deliver solutions in a practical, collaborative way, enabling companies to move with speed from lab to market," said Vince Wong, president and CEO of BioCrossroads, a non-profit organization that grows, advances, and invests in Indiana's life sciences and healthcare sectors. "When it comes to biosciences, people will think of Indiana the same as Boston, the Research Triangle of North Carolina, or even international locations like Zurich and Basel."

Indiana's bioscience industry currently generates more than $125 billion in annual economic impact and leads the nation in both life sciences and pharmaceutical exports.